|Brand name(s), other common name(s)||NINLARO®|
|Drug type||Proteasome inhibitor|
|How the drug is given||By mouth|
Indications and Usage
Ixazomib is FDA approved in combination with lenalidomide and dexamethasone for the treatment of patients with multiple myeloma who have received at least one prior therapy.
Side effects needing medical attention
Diarrhea, constipation, thrombocytopenia, peripheral neuropathy, nausea, peripheral edema, skin reactions, liver problems, vomiting, back pain.
For information on how to manage the costs of drug therapy, please see Financial Support, or to speak with an Information Specialist, call (800) 955-4572.